U.S. FDA declines to remove serious warning on Pfizer's Chantix

March 9, 2015 8:29 PM

6 0

U.S. FDA declines to remove serious warning on Pfizer's Chantix

(Reuters) - The U.S. Food and Drug Administration has declined to reduce the severity of its warning about neuropsychiatric side effects associated with Pfizer Inc's quit-smoking drug Chantix, the agency said on Monday.

The decision follows the recommendation of an advisory committee, which voted last October to keep information about the drug's psychiatric risks, including suicidal thoughts, hostility and agitation, highlighted inside a black box on the package label.

Also read: US Auto Safety Agency Wants You to Complain More

Read more

To category page

Loading...